Mouse-human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck.
Saved in:
| Title: | Mouse-human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck. |
|---|---|
| Authors: | Kim, Hye Ryun1 (AUTHOR), Kang, Han Na2 (AUTHOR), Yun, Mi Ran2 (AUTHOR), Ju, Kwon Young1 (AUTHOR), Choi, Jae Woo3 (AUTHOR), Jung, Dong Min3 (AUTHOR), Pyo, Kyoung Ho2 (AUTHOR), Hong, Min Hee1 (AUTHOR), Ahn, Myoung-Ju4 (AUTHOR), Sun, Jong-Mu4 (AUTHOR), Kim, Han Sang1 (AUTHOR), Kim, Jinna5 (AUTHOR), Yoo, Jinseon6 (AUTHOR), Kim, Kyu Ryung6 (AUTHOR), Koh, Yoon Woo7 (AUTHOR), Kim, Se Heon7 (AUTHOR), Choi, Eun Chang7 (AUTHOR), Yoon, Sun Ock8 (AUTHOR), Shim, Hyo Sup8 (AUTHOR), Paik, Soonmyung3,9 (AUTHOR) |
| Source: | British Journal of Cancer. 2020, Vol. 123 Issue 12, p1720-1729. 10p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00070920 |
|---|---|
| DOI: | 10.1038/s41416-020-01074-2 |
